Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
DSM-Firmenich AG is a science-driven specialty chemicals company focused on nutrition, health, and beauty solutions for global consumer and industrial markets. Headquartered in Kaiseraugst, Switzerland, the company develops and manufactures ingredients and systems that enhance the taste, texture, performance, and sustainability of end products across food, beverages, personal care, home care, and animal nutrition. Its activities are organized into four main segments: Perfumery & Beauty, Taste, Texture & Health, Health, Nutrition & Care, and Animal Nutrition & Health. These segments provide fragrances and flavors, vitamins, lipids, minerals, carotenoids, probiotics, enzymes, and other bioactive ingredients, alongside formulation and regulatory expertise for customers worldwide. DSM-Firmenich AG serves consumer goods companies, food and beverage producers, pharmaceutical and nutraceutical firms, and animal protein producers across Europe, the Americas, Asia, the Middle East, and Africa. The company positions itself as an innovator in natural and renewable ingredients, combining biotechnology, chemistry, and material science to support product differentiation and more sustainable consumer offerings.
Operating margin is thin at 7.00%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 0.2% YoY. The question is whether this is cyclical or a structural shift.
Free cash flow declined 35% versus the prior year, cash generation momentum has weakened. Net debt of €3.37B represents 5.2x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
€9.03B
▼ -0.2% YoY
Net Income (TTM)
-€1.04B
▼ -471.1% YoY
Op. Margin
7.00%
▲ +0.9pp YoY
ROIC
1.94%
▲ +0.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€651M
▼ -35.3% YoY
Op. Cash Flow (TTM)
€685M
▼ -32.6% YoY
Net Debt
€3.37B
Cash & Equiv.
€1.90B
3Y CAGR: +2.5%
3Y CAGR: +32.3%
Continue Research